Pfizer Ltd. News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Pfizer Ltd. from all sources in a single place.

08 Jul 2025

5468.00

-3.55%

Dividend stocks: Pfizer, 6 others to go ex-date on July 9; do you own any?

Business Standard

Here is the complete list of stocks that will trade ex-dividend on July 9, following their announcements of dividend rewards for shareholders

Pfizer Ltd. is trading above its 200 day SMA of 4936.3

Pfizer Ltd.

07 Jul 2025

5468.00

-3.55%

Company Update

Pfizer Ltd - 500680 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

We furnish herewith certificate confirming compliance with Regulation 74(5) of SEBI (Depository and Participants) Regulations, 2018 for the quarter ended June 30, 2025.

pdf

Pfizer Ltd.

02 Jul 2025

5468.00

-3.55%

Company Update

Pfizer Ltd - 500680 - Announcement under Regulation 30 (LODR)-Change in Management

BSE India

Intimation regarding change in Senior Management Personnel of the Company.

pdf

Pfizer Ltd.

30 Jun 2025

5468.00

-3.55%

Company Update

Pfizer Ltd - 500680 - Letter To Shareholders Providing The Weblink For Accessing The Annual Report.

BSE India

Please find enclosed letter to the shareholders pursuant to Regulation 36(1)(b) of SEBI LODR Regulations, 2015.

pdf

Pfizer Ltd.

30 Jun 2025

5468.00

-3.55%

Company Update

Pfizer Ltd - 500680 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Newspaper Advertisement - Notice of the 74th Annual General Meeting

pdf

Pfizer Ltd.

30 Jun 2025

5468.00

-3.55%

SAST

Pfizer Ltd - 500680 - Closure of Trading Window

BSE India

Closure of Trading window for the purpose of declaration of Unaudited Financial Results of the Company, for the quarter ending June 30, 2025.

pdf

Pfizer Ltd.

29 Jun 2025

5468.00

-3.55%

Corp. Note

Pfizer Ltd - 500680 - Business Responsibility and Sustainability Reporting (BRSR)

BSE India

We submit herewith the Business Responsibility and Sustainability Report for financial year 2024-25. The report also forms part of the Annual Report of FY 2024-25 submitted to the Exchange.

pdf

Pfizer Ltd.

29 Jun 2025

5468.00

-3.55%

Corp. Note

Pfizer Ltd - 500680 - Reg. 34 (1) Annual Report.

BSE India

We submit herewith the Annual Report of the Company for Financial Year 2024-25

pdf

Pfizer Ltd.

29 Jun 2025

5468.00

-3.55%

AGM

Pfizer Ltd - 500680 - Notice Of The 74Th Annual General Meeting Of The Company.

BSE India

Pursuant to Regulation 34 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we submit herewith notice of the 74th Annual General Meeting scheduled on Monday, July 21, 2025.

pdf

Pfizer Ltd.

31 May 2025

5468.00

-3.55%

Breast cancer: Pfizer-Arvinas drug beats AstraZeneca's in delaying disease's progression

Business Line

Trial finds Pfizer and Arvinas' experimental drug vepdegestrant increases survival without progression of breast cancer in patients with ESR1 mutations by five months

Pfizer Ltd.'s price crossed below 30Day SMA today

Is Pfizer Ltd. worth buying?

207 Votes:

Buy 73.91%

Sell 14.98%

Hold 11.11%